Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway
Here we first demonstrate that asperolide A, a very recently reported marine-derived tetranorditerpenoid, leads to the inhibition of NCI-H460 lung carcinoma cell proliferation by G2/M arrest with the activation of the Ras/Raf/MEK/ERK signaling and p53-dependent p21 pathway. Treatment with 35 μM aspe...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-01-01
|
Series: | Marine Drugs |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-3397/11/2/316 |
_version_ | 1828365236397146112 |
---|---|
author | Caiguo Huang Bingui Wang Ruohua Chen Shanjian Wei Haofen Sun Cuiting Lv Wenxia Sun |
author_facet | Caiguo Huang Bingui Wang Ruohua Chen Shanjian Wei Haofen Sun Cuiting Lv Wenxia Sun |
author_sort | Caiguo Huang |
collection | DOAJ |
description | Here we first demonstrate that asperolide A, a very recently reported marine-derived tetranorditerpenoid, leads to the inhibition of NCI-H460 lung carcinoma cell proliferation by G2/M arrest with the activation of the Ras/Raf/MEK/ERK signaling and p53-dependent p21 pathway. Treatment with 35 μM asperolide A (2 × IC50) resulted in a significant increase in the proportion of G2/M phase cells, about a 2.9-fold increase during 48 h. Immunoblot assays demonstrated time-dependent inhibition of G2/M regulatory proteins. Moreover, asperolide A significantly activated MAP kinases (ERK1/2, JNK and p38 MAP kinase) by phosphorylation, and only the inhibition of ERK activation by PD98059 reversed downregulation of G2/M regulatory proteins CDC2, and suppressed upregulation of p21 and p-p53 levels. Transfection of cells with dominant-negative Ras (RasN17) mutant genes up-regulated asperolide A-induced the decrease of cyclin B1 and CDC2, suppressed Raf, ERK activity and p53-p21 expression, and at last, abolished G2/M arrest. This study indicates that asperolide A-induced G2/M arrest in human NCI-H460 lung carcinoma cells relys on the participation of the Ras/Raf/MEK/ERK signaling pathway in p53-p21 stabilization. An in vivo study with asperolide A illustrated a marked inhibition of tumor growth, and little toxcity compared to Cisplatin therapy. Overall, these findings provide potential effectiveness and a theoretical basis for the therapeutic use of asperolide A in the treatment of malignancies. |
first_indexed | 2024-04-14T05:28:16Z |
format | Article |
id | doaj.art-79b4d137025142208acbe7b7bd4e1ee5 |
institution | Directory Open Access Journal |
issn | 1660-3397 |
language | English |
last_indexed | 2024-04-14T05:28:16Z |
publishDate | 2013-01-01 |
publisher | MDPI AG |
record_format | Article |
series | Marine Drugs |
spelling | doaj.art-79b4d137025142208acbe7b7bd4e1ee52022-12-22T02:09:55ZengMDPI AGMarine Drugs1660-33972013-01-0111231633110.3390/md11020316Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling PathwayCaiguo HuangBingui WangRuohua ChenShanjian WeiHaofen SunCuiting LvWenxia SunHere we first demonstrate that asperolide A, a very recently reported marine-derived tetranorditerpenoid, leads to the inhibition of NCI-H460 lung carcinoma cell proliferation by G2/M arrest with the activation of the Ras/Raf/MEK/ERK signaling and p53-dependent p21 pathway. Treatment with 35 μM asperolide A (2 × IC50) resulted in a significant increase in the proportion of G2/M phase cells, about a 2.9-fold increase during 48 h. Immunoblot assays demonstrated time-dependent inhibition of G2/M regulatory proteins. Moreover, asperolide A significantly activated MAP kinases (ERK1/2, JNK and p38 MAP kinase) by phosphorylation, and only the inhibition of ERK activation by PD98059 reversed downregulation of G2/M regulatory proteins CDC2, and suppressed upregulation of p21 and p-p53 levels. Transfection of cells with dominant-negative Ras (RasN17) mutant genes up-regulated asperolide A-induced the decrease of cyclin B1 and CDC2, suppressed Raf, ERK activity and p53-p21 expression, and at last, abolished G2/M arrest. This study indicates that asperolide A-induced G2/M arrest in human NCI-H460 lung carcinoma cells relys on the participation of the Ras/Raf/MEK/ERK signaling pathway in p53-p21 stabilization. An in vivo study with asperolide A illustrated a marked inhibition of tumor growth, and little toxcity compared to Cisplatin therapy. Overall, these findings provide potential effectiveness and a theoretical basis for the therapeutic use of asperolide A in the treatment of malignancies.http://www.mdpi.com/1660-3397/11/2/316asperolide AG2/M arrestp53-p21Ras/Raf/MEK/ERK signaling pathway |
spellingShingle | Caiguo Huang Bingui Wang Ruohua Chen Shanjian Wei Haofen Sun Cuiting Lv Wenxia Sun Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway Marine Drugs asperolide A G2/M arrest p53-p21 Ras/Raf/MEK/ERK signaling pathway |
title | Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway |
title_full | Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway |
title_fullStr | Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway |
title_full_unstemmed | Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway |
title_short | Asperolide A, a Marine-Derived Tetranorditerpenoid, Induces G2/M Arrest in Human NCI-H460 Lung Carcinoma Cells, Is Mediated by p53-p21 Stabilization and Modulated by Ras/Raf/MEK/ERK Signaling Pathway |
title_sort | asperolide a a marine derived tetranorditerpenoid induces g2 m arrest in human nci h460 lung carcinoma cells is mediated by p53 p21 stabilization and modulated by ras raf mek erk signaling pathway |
topic | asperolide A G2/M arrest p53-p21 Ras/Raf/MEK/ERK signaling pathway |
url | http://www.mdpi.com/1660-3397/11/2/316 |
work_keys_str_mv | AT caiguohuang asperolideaamarinederivedtetranorditerpenoidinducesg2marrestinhumanncih460lungcarcinomacellsismediatedbyp53p21stabilizationandmodulatedbyrasrafmekerksignalingpathway AT binguiwang asperolideaamarinederivedtetranorditerpenoidinducesg2marrestinhumanncih460lungcarcinomacellsismediatedbyp53p21stabilizationandmodulatedbyrasrafmekerksignalingpathway AT ruohuachen asperolideaamarinederivedtetranorditerpenoidinducesg2marrestinhumanncih460lungcarcinomacellsismediatedbyp53p21stabilizationandmodulatedbyrasrafmekerksignalingpathway AT shanjianwei asperolideaamarinederivedtetranorditerpenoidinducesg2marrestinhumanncih460lungcarcinomacellsismediatedbyp53p21stabilizationandmodulatedbyrasrafmekerksignalingpathway AT haofensun asperolideaamarinederivedtetranorditerpenoidinducesg2marrestinhumanncih460lungcarcinomacellsismediatedbyp53p21stabilizationandmodulatedbyrasrafmekerksignalingpathway AT cuitinglv asperolideaamarinederivedtetranorditerpenoidinducesg2marrestinhumanncih460lungcarcinomacellsismediatedbyp53p21stabilizationandmodulatedbyrasrafmekerksignalingpathway AT wenxiasun asperolideaamarinederivedtetranorditerpenoidinducesg2marrestinhumanncih460lungcarcinomacellsismediatedbyp53p21stabilizationandmodulatedbyrasrafmekerksignalingpathway |